Spruce Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Spruce Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Spruce Biosciences Inc
Rating: 1.70708325
Author: Trendlyne DVM scores

about

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT)...

77.80 -2.19 (-2.74%)

67.58% Fall from 52W High

40,203

XNAS Volume

XNAS 12 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

4.3 / 100

Technically Moderately Bullish

64.0 / 100

231

1Yr Price target upside is 196%

4 analysts

Spruce Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spruce Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT)...

67.58% Fall from 52W High

SWOT Analysis

Spruce Biosciences Inc Live Price Chart